Eli Lilly

Eli Lilly says its monoclonal antibody prevented Covid-19 infections in clinical trial
Eli Lilly says its monoclonal antibody prevented Covid-19 infections in clinical trial
Stat
Eli Lilly
monoclonal antibodies
clincial trials
COVID-19
Flag link:
AstraZeneca, Sanofi, Eli Lilly sue HHS over 340B opinion
AstraZeneca, Sanofi, Eli Lilly sue HHS over 340B opinion
Beckers Hospital Review
Eli Lilly
Sanofi
AstraZeneca
HHS
340B
discounts
Flag link:
Eli Lilly tees up discovery pact worth more than $1.6B with Merus for T cell-focused bispecific antibodies
Eli Lilly tees up discovery pact worth more than $1.6B with Merus for T cell-focused bispecific antibodies
Endpoints
Eli Lilly
oncology
Merus
drug discovery
Flag link:
Eli Lilly re-ups diversity pledge, pitching in $30M to venture fund for minority-owned healthcare firms
Eli Lilly re-ups diversity pledge, pitching in $30M to venture fund for minority-owned healthcare firms
Endpoints
Eli Lilly
venture capital
diversity
Flag link:
Could Lilly’s donanemab readout in Alzheimer’s boost Biogen’s prospects?
Could Lilly’s donanemab readout in Alzheimer’s boost Biogen’s prospects?
Pharmaforum
Eli Lilly
Alzheimer's disease
clinical trials
donanemab
Flag link:
A much-hyped CV drug failed, repeatedly. Now, investors are betting nearly $200M on one last PhIII bid
A much-hyped CV drug failed, repeatedly. Now, investors are betting nearly $200M on one last PhIII bid
Endpoints
Eli Lilly
cardiovascular disease
NewAmsterdam Pharma
CETP inhibitors
Flag link:
Boehringer, Lilly’s Jardiance ties to match AZ’s Farxiga with heart failure label
Boehringer, Lilly’s Jardiance ties to match AZ’s Farxiga with heart failure label
Pharmaforum
Boehringer Ingelheim
Eli Lilly
Jardiance
FDA
heart failure
fast track
Flag link:
Lilly rockets up on mixed Alzheimer's results
Lilly rockets up on mixed Alzheimer's results
BioPharma Dive
Eli Lilly
Alzheimer's disease
clinical trials
donanemab
Flag link:
Eli Lilly Partners with Blacksmith Medicines in $300 Million Seed Funding Deal
Eli Lilly Partners with Blacksmith Medicines in $300 Million Seed Funding Deal
BioSpace
Eli Lilly
Blacksmith Medicines
funding
metalloenzyme targets
Flag link:
BioGeneration Ventures closes 4th fund, with $170M in tow for early European biotechs
BioGeneration Ventures closes 4th fund, with $170M in tow for early European biotechs
Fierce Biotech
BioGeneration Ventures
venture capital
Europe
Bristol Myers Squibb
Eli Lilly
Novo Holdings
Flag link:
Dermira vets license back candidates from Eli Lilly to launch their own upstart
Dermira vets license back candidates from Eli Lilly to launch their own upstart
Endpoints
Demira
Eli Lilly
Evommune
Flag link:
Lilly, Amgen and more back advocacy group's push to double migraine research dollars
Lilly, Amgen and more back advocacy group's push to double migraine research dollars
Fierce Pharma
Eli Lilly
Amgen
migraines
Allergan
Novartis
Biohaven
Teva Pharmaceutical
Flag link:
Eli Lilly's transpacific bosom buddy Terns bags late-round funding to drive NASH hopefuls through the clinic
Eli Lilly's transpacific bosom buddy Terns bags late-round funding to drive NASH hopefuls through the clinic
Endpoints
NASH
Terns Pharmaceuticals
Eli Lilly
Flag link:
Eli Lilly to buy New York drugmaker for up to $1B
Eli Lilly to buy New York drugmaker for up to $1B
Beckers Hospital Review
Eli Lilly
Prevail Therapeutics
M&A
neurodegenerative disease
Flag link:
GlaxoSmithKline, Vir look to succeed where Lilly failed with NIH antibody study in hospitalized Covid-19 patients
GlaxoSmithKline, Vir look to succeed where Lilly failed with NIH antibody study in hospitalized Covid-19 patients
Endpoints
GSK
Vir Biotechnology
Eli Lilly
antibodies
NIH
COVID-19
clinical trials
Flag link:
Lilly and Regeneron COVID-19 antibodies are available all over the U.S. Why aren't they getting to more patients?
Lilly and Regeneron COVID-19 antibodies are available all over the U.S. Why aren't they getting to more patients?
Fierce Pharma
FDA
Eli Lilly
Regeneron
antibodies
COVID-19
Flag link:
13 drugmakers contracted by Operation Warp Speed in 2020
13 drugmakers contracted by Operation Warp Speed in 2020
Beckers Hospital Review
HHS
Operation Warp Speed
COVID-19
vaccines
Cytiva
Eli Lilly
AstraZeneca
Emergent BioSolutions
Fujifilm
JNJ
Moderna Therapeutics
Pfizer
BioNTech
Novavax
Regeneron
Sanofi
GSK
Flag link:
Lilly's Tirzepatide Significantly Reduced A1C and Body Weight in People with Type 2 Diabetes
Lilly's Tirzepatide Significantly Reduced A1C and Body Weight in People with Type 2 Diabetes
Drugs.com
Eli Lilly
tirzepatide
clinical trials
type 2 diabetes
diabetes
Flag link:
Lilly to acquire gene therapy specialist, Prevail Therapeutics, in a deal worth US$1.04bn
Lilly to acquire gene therapy specialist, Prevail Therapeutics, in a deal worth US$1.04bn
Biopharma Reporter
Eli Lilly
Prevail Therapeutics
M&A
Flag link:
Lilly's tirzepatide drives deep drops in blood sugar and body weight in diabetes phase 3
Lilly's tirzepatide drives deep drops in blood sugar and body weight in diabetes phase 3
Fierce Biotech
Eli Lilly
tirzepatide
type 2 diabetes
clinical trials
Flag link:

Pages